Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
11,93 AUD | +0,51% | +1,53% | -2,45% |
30/04 | Evotec, Bayer gaan zich richten op precisiebehandelingen voor hart- en vaatziekten | MT |
24/04 | Duits Evotec benoemt permanente CEO | MT |
Omzet 2024 * | 1,18 mld. 776 mln. 721 mln. | Omzet 2025 * | 1,31 mld. 865 mln. 804 mln. | Marktkapitalisatie | 1,94 mld. 1,28 mld. 1,19 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 24 mln. 15,86 mln. 14,74 mln. | Nettowinst (verlies) 2025 * | 73 mln. 48,24 mln. 44,82 mln. | EV/omzet 2024 * | 2,7 x |
Nettoschuld 2024 * | 1,23 mld. 815 mln. 757 mln. | Nettoschuld 2025 * | 1,24 mld. 818 mln. 760 mln. | EV/omzet 2025 * | 2,42 x |
K/w-verhouding 2024 * |
74,2
x | K/w-verhouding 2025 * |
25,5
x | Werknemers | - |
Dividendrendement 2024 * |
1,17% | Dividendrendement 2025 * |
2,69% | Vrij verhandelbaar | 72,31% |
Recentste transcriptie over EVT Limited
1 dag | +0,51% | ||
1 week | +1,53% | ||
Lopende maand | -0,83% | ||
1 maand | -0,58% | ||
3 maanden | -5,09% | ||
6 maanden | +9,95% | ||
Lopend jaar | -2,45% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jane Hastings
CEO | Chief Executive Officer | - | 01-08-16 |
Gregory Dean
DFI | Director of Finance/CFO | 58 | 01-12-02 |
Jordan Rodgers
PRN | Corporate Officer/Principal | - | 01-05-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Rydge
CHM | Chairman | 71 | 01-01-78 |
Valerie Davies
BRD | Director/Board Member | 73 | 20-04-11 |
Director/Board Member | 78 | 10-07-09 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3,35% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
03-05-24 | 11,93 | +0,51% | 96 556 |
02-05-24 | 11,87 | +0,76% | 130 005 |
01-05-24 | 11,78 | -2,08% | 127 315 |
30-04-24 | 12,03 | -0,41% | 68 869 |
29-04-24 | 12,08 | +2,81% | 109 146 |
uitgestelde koers Australian S.E., 03 mei 2024 om 08:10 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,45% | 1,28 mld. | |
+12,37% | 4,41 mld. | |
+25,76% | 2,17 mld. | |
-.--% | 1,93 mld. | |
-20,36% | 1,55 mld. | |
-7,87% | 1,44 mld. | |
-10,63% | 1,15 mld. | |
-18,52% | 1,14 mld. | |
-46,16% | 912 mln. | |
-.--% | 818 mln. |